Other OTC Pharmaceuticals (Pharmacies) - Bulgaria

  • Bulgaria
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$137.10m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.27%, resulting in a market volume of US$146.00m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$20.71 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Bulgaria has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in the Bulgarian market have shifted towards self-medication and over-the-counter (OTC) pharmaceuticals. Consumers are increasingly seeking convenience and affordability when it comes to managing their healthcare needs. This has led to a greater demand for OTC products, as they offer a wide range of options for treating common ailments without the need for a prescription. Additionally, the growing awareness of the benefits of preventive healthcare has also contributed to the rise in demand for OTC pharmaceuticals. Trends in the market indicate that the Bulgarian population is becoming more health-conscious and proactive in managing their health. This has led to an increased demand for OTC pharmaceuticals that cater to specific health concerns, such as vitamins and supplements, pain relief medication, and digestive health products. The availability of a wide range of OTC products in pharmacies across the country has further fueled this trend. Pharmacies have also responded to this demand by expanding their product offerings and providing personalized advice to customers. Local special circumstances in Bulgaria have also played a role in the development of the Other OTC Pharmaceuticals market. The country's healthcare system has undergone significant reforms in recent years, resulting in increased access to healthcare services for the population. This has led to a greater emphasis on preventive care and self-management of minor health issues. Additionally, the growing middle class in Bulgaria has more disposable income to spend on healthcare products, including OTC pharmaceuticals. Underlying macroeconomic factors have also contributed to the growth of the Other OTC Pharmaceuticals market in Bulgaria. The country has experienced steady economic growth in recent years, which has led to an increase in consumer spending. This has provided individuals with the financial means to purchase OTC pharmaceuticals for their healthcare needs. Furthermore, the aging population in Bulgaria has also contributed to the growth of the market, as older individuals often require OTC products for managing chronic conditions and maintaining their health. In conclusion, the Other OTC Pharmaceuticals market in Bulgaria is developing due to customer preferences for self-medication and convenience, trends towards proactive healthcare management, local special circumstances such as healthcare reforms and a growing middle class, and underlying macroeconomic factors such as economic growth and an aging population. These factors have created a favorable environment for the growth of the market, and it is expected to continue expanding in the coming years.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)